Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Mira

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Acta Haematologica|January 1, 1983
Spanish delta-beta-thalassemia: hematological studies and composition of the gamma-chains in ten homozygous patientsM Baiget, E Gimferrer, I Fernández, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|April 9, 2001
Spontaneous cervical epidural hematoma associated with oral anticoagulant therapyA Vayá, M Resurección, J M Ricart, et al.
Thrombosis and Haemostasis|January 5, 2002
Low level of circulating activated protein C is a risk factor for venous thromboembolismF España, A Vayá, Y Mira, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|July 18, 2000
Portal vein thrombosis associated to prothrombin G20210A mutation and protein C deficiencyY Mira, G García del Castillo, A Estellés, et al.
Haematologica|March 26, 1999
Factor V Leiden and antibodies against phospholipids and protein S in a young woman with recurrent thromboses and abortionF España, P Villa, Y Mira, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|February 24, 2001
Upper extremity deep vein thrombosis in a young patient double heterozygous for factor V Leiden and prothrombin G20210A mutationA Vayá, J Todolí, J Ricart, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 22, 2000
Central retinal vein thrombosis associated with prothrombin 20210G/A gene variantA Vayá, J M López, Y Mira, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|July 10, 2001
Factor V Leiden and prothrombin G20210A in relation to arterial and/or vein rethrombosis: two casesY Mira, T Todolí, R Alonso, et al.
British Journal of Haematology|November 25, 2000
PAI-1 promoter 4G/5G genotype as an additional risk factor for venous thrombosis in subjects with genetic thrombophilic defectsR Seguí, A Estellés, Y Mira, et al.
Haematologica|December 13, 2000
Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptivesJ Aznar, A Vayá, A Estellés, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Acta Haematologica|January 1, 1983
Spanish delta-beta-thalassemia: hematological studies and composition of the gamma-chains in ten homozygous patientsM Baiget, E Gimferrer, I Fernández, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|April 9, 2001
Spontaneous cervical epidural hematoma associated with oral anticoagulant therapyA Vayá, M Resurección, J M Ricart, et al.
Thrombosis and Haemostasis|January 5, 2002
Low level of circulating activated protein C is a risk factor for venous thromboembolismF España, A Vayá, Y Mira, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|July 18, 2000
Portal vein thrombosis associated to prothrombin G20210A mutation and protein C deficiencyY Mira, G García del Castillo, A Estellés, et al.
Haematologica|March 26, 1999
Factor V Leiden and antibodies against phospholipids and protein S in a young woman with recurrent thromboses and abortionF España, P Villa, Y Mira, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|February 24, 2001
Upper extremity deep vein thrombosis in a young patient double heterozygous for factor V Leiden and prothrombin G20210A mutationA Vayá, J Todolí, J Ricart, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 22, 2000
Central retinal vein thrombosis associated with prothrombin 20210G/A gene variantA Vayá, J M López, Y Mira, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|July 10, 2001
Factor V Leiden and prothrombin G20210A in relation to arterial and/or vein rethrombosis: two casesY Mira, T Todolí, R Alonso, et al.
British Journal of Haematology|November 25, 2000
PAI-1 promoter 4G/5G genotype as an additional risk factor for venous thrombosis in subjects with genetic thrombophilic defectsR Seguí, A Estellés, Y Mira, et al.
Haematologica|December 13, 2000
Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptivesJ Aznar, A Vayá, A Estellés, et al.
Pageof 3